- 2024.10.2
- Event We will have a booth V-26 at Japan Healthcare Venture Summit 2024 on Oct 9th-11th
- 2024.8.26
- Patents, Articles & Conferences Results of collaboration project with Prof. Sando Lab (The University of Tokyo) will be presented at XXV International Round Table on Nucleosides, Nucleotides and Nucleic Acids (IRT2024)
- 2024.8.8
- Patents, Articles & Conferences We will be presenting Hunner-type Interstitial Cystitis project at ICICJ (August 21st-23rd at Kyoto)
- 2024.7.1
- Patents, Articles & Conferences Announcement of presentation at the 9th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan (July 15th – 18th, 2024)
- 2024.5.1
- Patents, Articles & Conferences We will be presenting our Dry eye project results at ARVO 2024 (May 5th – 9th at Seattle)
- 2024.3.13
- News Release Prof. Yohei Yamauchi of ETH Zurich and TAGCyx Announces a Research Collaboration for the discovery of a novel Xenoligo® aptamer in the field of infectious diseases field.
- 2024.3.11
- News Release Shinji Oki, PhD, at National Center of Neurology and Psychiatry and TAGCyx Announces a research collaboration for the treatment for systemic lupus erythematosus using a novel nucleic acid aptamer.
- 2024.1.31
- News Release SBI Pharmaceuticals and TAGCyx ANNOUNCES A MILESTONE ACHIEVEMENT OF THE RESEARCH AND DEVELOPMENT COLLABORATION OF INNOVATIVE CANCER THERAPY
- 2024.1.4
- News Release TAGCyx and Toray Launch Joint Research Initiative to Combat Preeclampsia during Pregnancy as Part of Efforts to Stem Japan’s Declining Birthrate
- 2023.12.12
- News Release TAGCyx has executed a joint research and development agreement with Teika Pharmaceutical
- 2024.8.26
- Patents, Articles & Conferences Results of collaboration project with Prof. Sando Lab (The University of Tokyo) will be presented at XXV International Round Table on Nucleosides, Nucleotides and Nucleic Acids (IRT2024)
- 2024.8.8
- Patents, Articles & Conferences We will be presenting Hunner-type Interstitial Cystitis project at ICICJ (August 21st-23rd at Kyoto)
- 2024.7.1
- Patents, Articles & Conferences Announcement of presentation at the 9th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan (July 15th – 18th, 2024)
- 2024.5.1
- Patents, Articles & Conferences We will be presenting our Dry eye project results at ARVO 2024 (May 5th – 9th at Seattle)
- 2024.2.29
- Patents, Articles & Conferences We will be presenting Xenoligo® Technology at Aptamers 2024 (March 18th – 19th at Oxford)
- 2024.10.2
- Event We will have a booth V-26 at Japan Healthcare Venture Summit 2024 on Oct 9th-11th
- 2023.9.13
- Event We will have a booth V-36 at Japan Healthcare Venture Summit 2023 on Oct 11st-13rd
- 2022.12.23
- Event TAGCyx will be attending 41st Annual J.P. Morgan Healthcare Conference
- 2022.7.13
- Event ‘The 3rd Aptamer Seminar in Tokyo ~virtual meeting~’ will be held on September 2, 2022.
- 2021.10.8
- Event We will have a booth V2 at Japan Healthcare Venture Summit Oct 13th-15th
- 2023.10.3
- Information Science Impact magazine published an article about the treatment for Hunner-type interstitial cystitis using TAGCyx’s aptamer, TAGX-0003.
- 2023.5.29
- Information Announcing the renovating of TAGCyx website
- 2021.8.10
- Information Pipeline is updated
- 2020.6.22
- Information We updated in-house pipeline
- 2020.6.1
- Information TAGCyx established an Audit & Supervisory Board